Showing results (51-60 of 113) with videos related to
Sort By:
Pageof 12
Journal of Virology|October 29, 2005
A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicityMilosz Faber, Marie-Luise Faber, Amy Papaneri, et al.Journal of Virology|April 27, 2007
Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virusMilosz Faber, Marie-Luise Faber, Jianwei Li, et al.Vaccine|August 14, 2012
Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoproteinAmy B Papaneri, Christoph Wirblich, Kurt Cooper, et al.NPJ Vaccines|April 25, 2019
Rabies-based vaccine induces potent immune responses against Nipah virusRohan Keshwara, Thomas Shiels, Elena Postnikova, et al.Vaccine|November 9, 2004
In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlifeMarie-Luise Dietzschold, Milosz Faber, Jeffrey A Mattis, et al.Virology|February 17, 2006
siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effectsRajnish S Dave, James P McGettigan, Tazeen Qureshi, et al.Plos Pathogens|July 28, 2010
Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signalingElizabeth J Faul, Celestine N Wanjalla, Mehul S Suthar, et al.Vaccine|September 23, 2008
Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein geneJonathan Cenna, Gene S Tan, Amy B Papaneri, et al.Journal of Virology|April 24, 2020
Identification and Characterization of a Small-Molecule Rabies Virus Entry InhibitorVenice Du Pont, Christoph Wirblich, Jeong-Joong Yoon, et al.The Journal of General Virology|April 16, 2005
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodiesMilosz Faber, Elaine W Lamirande, Anjeanette Roberts, et al.Pageof 12